Traducción en proceso. Mostrando versión en inglés.

Earnings call transcript: LKQ’s Q4 2025 results miss EPS expectations, stock dips

ArchivadoVerificado|4 artículos|2 fuentes|1 bloques

Detectado: Actualizado: Analizado:

Automotriz

Hechos Reportados

Datos observables compartidos por todas las narrativas

•LKQ Corporation reported Q4 2025 results that missed analyst expectations on earnings per share.
•Following the Q4 2025 earnings release and call, LKQ’s stock price declined.
•Telix Pharmaceuticals reported GAAP EPS of -$2.11, missing analyst expectations by $2.14.
•Telix Pharmaceuticals reported revenue of $803.8 million, missing revenue expectations by $22.79 million.
•F&G Annuities & Life reported Non-GAAP EPS of $0.91, missing analyst expectations by $0.29.
•F&G Annuities & Life reported revenue of $2.3 billion, exceeding revenue expectations by $750 million.

Qué Podría Pasar Si...

▸If LKQ’s management guides to weaker-than-expected earnings or margins for 2026 during or after the Q4 2025 call Institutional investors may further reduce exposure to LKQ, increasing downside pressure on the stock and potentially widening its valuation discount versus sector peers.

Inicia sesión para ver todos los escenarios y señales.

Exposición de Mercado

AccionesLKQ Corporation (LKQ)Mayor Volatilidad

If investors reassess LKQ’s growth and margin outlook after the Q4 2025 EPS miss, trading activity could rise and lead to larger short-term price swings.